TCM
DRTSW icon

Tuttle Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Tuttle Capital Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,882
Closed -$2.97K – 49
2022
Q4 		$2.97K Buy
+11,882
New +$3.64K 0.01% 64

Other funds holding DRTSW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Tuttle Capital Management's DRTSW Position: Q1 2023 in Review

Tuttle Capital Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2023, closing a stake of 11,882 shares — an estimated $2.97K sold.

Tuttle Capital Management first reported a position in DRTSW in Q4 2022 and held it in 1 quarter. The position peaked at $2.97K in Q4 2022. 32 funds tracked by Wall St. Rank hold DRTSW as of Q1 2023.

  • Tuttle Capital Management reported no remaining Alpha Tau Medical Warrant position as of Q1 2023 after selling out during the quarter.
  • Tuttle Capital Management sold 11,882 Alpha Tau Medical Warrant shares in Q1 2023, an estimated $2.97K.
  • Tuttle Capital Management first reported a position in Alpha Tau Medical Warrant in Q4 2022 and held it in 1 quarter.
  • Tuttle Capital Management's Alpha Tau Medical Warrant position peaked at $2.97K in Q4 2022.
  • 32 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2023.

Based on Tuttle Capital Management's 13F filing for Q1 2023, filed 7 Apr 2023.